Assessing the impact of antimicrobial resistance policies on antibiotic use and antimicrobial resistance-associated mortality in children and adults in low and middle-income countries: a global analysis

Introduction Antimicrobial resistance (AMR) poses a major threat to global health security today. In recent years, many low and middle-income countries (LMICs) have implemented policies to optimise antibiotic use in both formal and informal healthcare settings. However, there is limited evidence on...

Full description

Saved in:
Bibliographic Details
Main Authors: Günther Fink, Jay Patel, Kyaw Zay Ya
Format: Article
Language:English
Published: BMJ Publishing Group 2025-02-01
Series:BMJ Public Health
Online Access:https://bmjpublichealth.bmj.com/content/3/1/e000511.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823858022657556480
author Günther Fink
Jay Patel
Kyaw Zay Ya
author_facet Günther Fink
Jay Patel
Kyaw Zay Ya
author_sort Günther Fink
collection DOAJ
description Introduction Antimicrobial resistance (AMR) poses a major threat to global health security today. In recent years, many low and middle-income countries (LMICs) have implemented policies to optimise antibiotic use in both formal and informal healthcare settings. However, there is limited evidence on the effectiveness of these national efforts in LMICs.Methods We investigated the empirical relationship between national policies aimed at restricting antibiotic use and actual antibiotic consumption in 138 LMICs. Data on national policies were obtained from the Tripartite AMR Country Self-Assessment Survey (TrACSS) as well as from the Global Survey of Experts on AMR (GSEAR). Seven independent variables relating to AMR policies were evaluated. Outcomes included the proportion of children receiving antibiotics for lower respiratory tract infections and diarrhoea (specific to paediatric populations), along with total antibiotic consumption and AMR-associated mortality in general populations.Results Our analysis of 138 LMICs found wide variation in antibiotic use between countries and regions. We observed strong evidence of negative association (mean difference MD=−0.150, 95% CI (−0.2593 to –0.0407)) between the presence of regulatory or legislative policies that ban over-the-counter sales of antibiotics and the proportion of children receiving antibiotic drugs for lower respiratory tract infection. Furthermore, stronger AMR governance was associated with reduced total antibiotic consumption at the country level (MD=−1.259, 95% CI (−2.297 to –0.2216)). No associations were found between other policy variables and antibiotic use or mortality.Conclusion The results presented here suggest that there is some evidence of an empirical relationship between national policies aimed at limiting over-the-counter antibiotic sales and actual antibiotic usage practices. Further policy effectiveness research will be needed to better understand the true impact of government measures. In general, a multifaceted approach will likely be needed to fight AMR and preserve antibiotics’ effectiveness, including evidence-based policies, targeted education and research.
format Article
id doaj-art-ffc6a054859c42d9a67273b4d5efea83
institution Kabale University
issn 2753-4294
language English
publishDate 2025-02-01
publisher BMJ Publishing Group
record_format Article
series BMJ Public Health
spelling doaj-art-ffc6a054859c42d9a67273b4d5efea832025-02-11T17:30:12ZengBMJ Publishing GroupBMJ Public Health2753-42942025-02-013110.1136/bmjph-2023-000511Assessing the impact of antimicrobial resistance policies on antibiotic use and antimicrobial resistance-associated mortality in children and adults in low and middle-income countries: a global analysisGünther Fink0Jay Patel1Kyaw Zay Ya2University of Basel, Basel, Switzerland3 Centre for Population Health Sciences, The University of Edinburgh Usher Institute, Edinburgh, UK1 Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Allschwil, SwitzerlandIntroduction Antimicrobial resistance (AMR) poses a major threat to global health security today. In recent years, many low and middle-income countries (LMICs) have implemented policies to optimise antibiotic use in both formal and informal healthcare settings. However, there is limited evidence on the effectiveness of these national efforts in LMICs.Methods We investigated the empirical relationship between national policies aimed at restricting antibiotic use and actual antibiotic consumption in 138 LMICs. Data on national policies were obtained from the Tripartite AMR Country Self-Assessment Survey (TrACSS) as well as from the Global Survey of Experts on AMR (GSEAR). Seven independent variables relating to AMR policies were evaluated. Outcomes included the proportion of children receiving antibiotics for lower respiratory tract infections and diarrhoea (specific to paediatric populations), along with total antibiotic consumption and AMR-associated mortality in general populations.Results Our analysis of 138 LMICs found wide variation in antibiotic use between countries and regions. We observed strong evidence of negative association (mean difference MD=−0.150, 95% CI (−0.2593 to –0.0407)) between the presence of regulatory or legislative policies that ban over-the-counter sales of antibiotics and the proportion of children receiving antibiotic drugs for lower respiratory tract infection. Furthermore, stronger AMR governance was associated with reduced total antibiotic consumption at the country level (MD=−1.259, 95% CI (−2.297 to –0.2216)). No associations were found between other policy variables and antibiotic use or mortality.Conclusion The results presented here suggest that there is some evidence of an empirical relationship between national policies aimed at limiting over-the-counter antibiotic sales and actual antibiotic usage practices. Further policy effectiveness research will be needed to better understand the true impact of government measures. In general, a multifaceted approach will likely be needed to fight AMR and preserve antibiotics’ effectiveness, including evidence-based policies, targeted education and research.https://bmjpublichealth.bmj.com/content/3/1/e000511.full
spellingShingle Günther Fink
Jay Patel
Kyaw Zay Ya
Assessing the impact of antimicrobial resistance policies on antibiotic use and antimicrobial resistance-associated mortality in children and adults in low and middle-income countries: a global analysis
BMJ Public Health
title Assessing the impact of antimicrobial resistance policies on antibiotic use and antimicrobial resistance-associated mortality in children and adults in low and middle-income countries: a global analysis
title_full Assessing the impact of antimicrobial resistance policies on antibiotic use and antimicrobial resistance-associated mortality in children and adults in low and middle-income countries: a global analysis
title_fullStr Assessing the impact of antimicrobial resistance policies on antibiotic use and antimicrobial resistance-associated mortality in children and adults in low and middle-income countries: a global analysis
title_full_unstemmed Assessing the impact of antimicrobial resistance policies on antibiotic use and antimicrobial resistance-associated mortality in children and adults in low and middle-income countries: a global analysis
title_short Assessing the impact of antimicrobial resistance policies on antibiotic use and antimicrobial resistance-associated mortality in children and adults in low and middle-income countries: a global analysis
title_sort assessing the impact of antimicrobial resistance policies on antibiotic use and antimicrobial resistance associated mortality in children and adults in low and middle income countries a global analysis
url https://bmjpublichealth.bmj.com/content/3/1/e000511.full
work_keys_str_mv AT guntherfink assessingtheimpactofantimicrobialresistancepoliciesonantibioticuseandantimicrobialresistanceassociatedmortalityinchildrenandadultsinlowandmiddleincomecountriesaglobalanalysis
AT jaypatel assessingtheimpactofantimicrobialresistancepoliciesonantibioticuseandantimicrobialresistanceassociatedmortalityinchildrenandadultsinlowandmiddleincomecountriesaglobalanalysis
AT kyawzayya assessingtheimpactofantimicrobialresistancepoliciesonantibioticuseandantimicrobialresistanceassociatedmortalityinchildrenandadultsinlowandmiddleincomecountriesaglobalanalysis